Literature DB >> 24891107

Colonization of cecum is important for development of persistent infection by Yersinia pseudotuberculosis.

Anna Fahlgren1, Kemal Avican2, Linda Westermark2, Roland Nordfelth3, Maria Fällman2.   

Abstract

Yersiniosis is a human disease caused by the bacterium Yersinia pseudotuberculosis or Yersinia enterocolitica. The infection is usually resolved but can lead to postinfectious sequelae, including reactive arthritis and erythema nodosum. The commonly used Yersinia mouse infection model mimics acute infection in humans to some extent but leads to systemic infection and eventual death. Here, we analyzed sublethal infection doses of Y. pseudotuberculosis in mice in real time using bioluminescent imaging and found that infections using these lower doses result in extended periods of asymptomatic infections in a fraction of mice. In a search for the site for bacterial persistence, we found that the cecum was the primary colonization site and was the site where the organism resided during a 115-day infection period. Persistent infection was accompanied by sustained fecal shedding of cultivable bacteria. Cecal patches were identified as the primary site for cecal colonization during persistence. Y. pseudotuberculosis bacteria were present in inflammatory lesions, in localized foci, or as single cells and also in neutrophil exudates in the cecal lumen. The chronically colonized cecum may serve as a reservoir for dissemination of infection to extraintestinal sites, and a chronic inflammatory state may trigger the onset of postinfectious sequelae. This novel mouse model for bacterial persistence in cecum has potential as an investigative tool to unveil a deeper understanding of bacterial adaptation and host immune defense mechanisms during persistent infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24891107      PMCID: PMC4136198          DOI: 10.1128/IAI.01793-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Roles of the H-2D(b) and H-K(b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system.

Authors:  Arièle Azoulay-Cayla; Sylvie Syan; Michel Brahic; Jean-François Bureau
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

Review 2.  Reactive arthritis.

Authors:  A Toivanen; P Toivanen
Journal:  Curr Opin Rheumatol       Date:  2000-07       Impact factor: 5.006

Review 3.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

4.  Occurrence of pathogenic Yersinia enterocolitica and Yersinia pseudotuberculosis in small wild rodents.

Authors:  A Backhans; C Fellström; S Thisted Lambertz
Journal:  Epidemiol Infect       Date:  2010-11-15       Impact factor: 2.451

5.  Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: correlation with specific serum IgA antibodies.

Authors:  J de Koning; J Heesemann; J A Hoogkamp-Korstanje; J J Festen; P M Houtman; P L van Oijen
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

6.  Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death.

Authors:  D M Monack; J Mecsas; N Ghori; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

Review 7.  Bacteria as trigger for chronic gastrointestinal disorders.

Authors:  Philippe Marteau; Ulriikka Chaput
Journal:  Dig Dis       Date:  2011-07-05       Impact factor: 2.404

8.  Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction.

Authors:  Ulrich Meinzer; Frederick Barreau; Sophie Esmiol-Welterlin; Camille Jung; Claude Villard; Thibaut Léger; Sanah Ben-Mkaddem; Dominique Berrebi; Monique Dussaillant; Ziad Alnabhani; Maryline Roy; Stéphane Bonacorsi; Hans Wolf-Watz; Julie Perroy; Vincent Ollendorff; Jean-Pierre Hugot
Journal:  Cell Host Microbe       Date:  2012-04-19       Impact factor: 21.023

Review 9.  The basis of persistent bacterial infections.

Authors:  Mikael Rhen; Sofia Eriksson; Mark Clements; Sven Bergström; Staffan J Normark
Journal:  Trends Microbiol       Date:  2003-02       Impact factor: 17.079

10.  Comparison of the cytokine immune response to pathogenic Yersinia enterocolitica bioserotype 1B/O:8 and 2/O:9 in susceptible BALB/C and resistant C57BL/6 mice.

Authors:  Xin Wang; Wenpeng Gu; Haiyan Qiu; Shengli Xia; Han Zheng; Yuchun Xiao; Junrong Liang; Huaiqi Jing
Journal:  Mol Immunol       Date:  2013-04-10       Impact factor: 4.407

View more
  16 in total

1.  The Tat Substrate SufI Is Critical for the Ability of Yersinia pseudotuberculosis To Cause Systemic Infection.

Authors:  Ummehan Avican; Tugrul Doruk; Yngve Östberg; Anna Fahlgren; Åke Forsberg
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

2.  Yersinia pseudotuberculosis Blocks Neutrophil Degranulation.

Authors:  Nayyer Taheri; Anna Fahlgren; Maria Fällman
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

3.  Microbiota-Dependent Sequelae of Acute Infection Compromise Tissue-Specific Immunity.

Authors:  Denise Morais da Fonseca; Timothy W Hand; Seong-Ji Han; Michael Y Gerner; Arielle Glatman Zaretsky; Allyson L Byrd; Oliver J Harrison; Alexandra M Ortiz; Mariam Quinones; Giorgio Trinchieri; Jason M Brenchley; Igor E Brodsky; Ronald N Germain; Gwendalyn J Randolph; Yasmine Belkaid
Journal:  Cell       Date:  2015-10-08       Impact factor: 41.582

Review 4.  One for All, but Not All for One: Social Behavior during Bacterial Diseases.

Authors:  Kimberly M Davis; Ralph R Isberg
Journal:  Trends Microbiol       Date:  2018-09-19       Impact factor: 17.079

5.  Transcriptomic profiling of Yersinia pseudotuberculosis reveals reprogramming of the Crp regulon by temperature and uncovers Crp as a master regulator of small RNAs.

Authors:  Aaron M Nuss; Ann Kathrin Heroven; Barbara Waldmann; Jan Reinkensmeier; Michael Jarek; Michael Beckstette; Petra Dersch
Journal:  PLoS Genet       Date:  2015-03-27       Impact factor: 5.917

6.  Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.

Authors:  Anne Derbise; Yuri Hanada; Manal Khalifé; Elisabeth Carniel; Christian E Demeure
Journal:  PLoS Negl Trop Dis       Date:  2015-10-16

7.  Reprogramming of Yersinia from virulent to persistent mode revealed by complex in vivo RNA-seq analysis.

Authors:  Kemal Avican; Anna Fahlgren; Mikael Huss; Ann Kathrin Heroven; Michael Beckstette; Petra Dersch; Maria Fällman
Journal:  PLoS Pathog       Date:  2015-01-15       Impact factor: 6.823

8.  A Precise Temperature-Responsive Bistable Switch Controlling Yersinia Virulence.

Authors:  Aaron Mischa Nuss; Franziska Schuster; Louisa Roselius; Johannes Klein; René Bücker; Katharina Herbst; Ann Kathrin Heroven; Fabio Pisano; Christoph Wittmann; Richard Münch; Johannes Müller; Dieter Jahn; Petra Dersch
Journal:  PLoS Pathog       Date:  2016-12-22       Impact factor: 6.823

Review 9.  All Yersinia Are Not Created Equal: Phenotypic Adaptation to Distinct Niches Within Mammalian Tissues.

Authors:  Kimberly M Davis
Journal:  Front Cell Infect Microbiol       Date:  2018-08-03       Impact factor: 5.293

10.  Loss of CNFY toxin-induced inflammation drives Yersinia pseudotuberculosis into persistency.

Authors:  Wiebke Heine; Michael Beckstette; Ann Kathrin Heroven; Sophie Thiemann; Ulrike Heise; Aaron Mischa Nuss; Fabio Pisano; Till Strowig; Petra Dersch
Journal:  PLoS Pathog       Date:  2018-02-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.